Shares of ValiRx plc (LON:VAL – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 2.40 ($0.03) and traded as low as GBX 1.45 ($0.02). ValiRx shares last traded at GBX 1.53 ($0.02), with a volume of 143,913 shares traded.
ValiRx Stock Down 1.6 %
The company has a current ratio of 6.65, a quick ratio of 1.27 and a debt-to-equity ratio of 0.49. The stock has a 50-day simple moving average of GBX 1.69 and a 200-day simple moving average of GBX 2.40. The company has a market cap of £2.02 million, a price-to-earnings ratio of -76.25 and a beta of 0.59.
About ValiRx
ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer.
Featured Articles
- Five stocks we like better than ValiRx
- P/E Ratio Calculation: How to Assess Stocks
- What a Trump Win Looks Like for the Market Now and Into 2025
- What is a buyback in stocks? A comprehensive guide for investors
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
